News

The U.S. Food and Drug Administration has approved Arcutis Biotherapeutics' Zoryve (roflumilast) topical foam 0.3% for the ...
The Food and Drug Administration has approved Zoryve (roflumilast) topical foam, 0.3% for plaque psoriasis of the scalp and body.
Dr. Jason Rivers, MD, FRCPC, discusses psoriasis symptoms and treatments.
Menthol is extracted from mint plants, creating a cooling sensation and providing temporary relief through counter-irritation ...
Biocon share rose after arm, Biocon Biologics, was granted market authorisation in the UK for Yesintek, a biosimilar of ...
8% of patients maintained that the ongoing war had affected the quality of the treatment they are receiving for psoriasis.
Skincare products are yet to crack a one-size-fits-all formula, and the same stands for lip care as well, because as people, ...
Users call it “without a doubt the best sunscreen I have ever used ,” and “a must-have in my middle-aged skincare routine,” ...
Originating in Korea, “topical spicule products contain microscopic needle-like structures that gently penetrate the upper ...
Opinion
The Nature of Neurocosmetics
With skincare trends popping up and fading away faster than Easter egg moments in films, this week I’m diving straight into neurocosmetics. This isn’t just a pa ...
Bengaluru: Biocon Biologics Ltd, a fully integrated global biosimilars company and subsidiary of Biocon Ltd., has received ...